# FDA recall D-1202-2019

> **Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy** · Class II · drug recall initiated 2019-04-02.

## Product

Prostaglandin Tri-Mix 8.33:22.5:0.833 Injection, 2 mL Vial, Anderson Compounding Pharmacy 310 Bluff City Hwy, Bristol, TN.

## Reason for recall

Lack of sterility assurance.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-1202-2019
- **Recalling firm:** Anderson Compounding Pharmacy, Inc. DBA Anderson Compounding Pharmacy
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2019-04-02
- **Report date:** 2019-04-24
- **Termination date:** 2021-09-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Bristol, TN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1202-2019

## Citation

> AI Analytics. FDA recall D-1202-2019. Retrieved 2026-05-29 from https://api.ai-analytics.org/recall/D-1202-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*